Venomous snakebites worldwide with a focus on the Australia-Pacific region: Current management and controversies

Journal of Intensive Care Medicine

Volumn 19, Issue 5, 2004, Pages 259-269

  Cheng, Allen C ^a,b   Currie, Bart J ^a,b,c  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c ROYAL DARWIN HOSPITAL   (Australia)

Author keywords

Antivenins; Antivenoms; Blood coagulation disorders; Developing countries; Neurotoxins; Snakebites

Indexed keywords

VENOM ANTISERUM;

AUSTRALIA; FIRST AID; HEALTH; HUMAN; METHODOLOGY; PACIFIC ISLANDS; PATHOPHYSIOLOGY; REVIEW; SNAKEBITE;

ANTIVENINS; AUSTRALIA; FIRST AID; HUMANS; PACIFIC ISLANDS; SNAKE BITES; WORLD HEALTH;

EID: 16544390601     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066604265799     Document Type: Review

References (92)

1. Chippaux JP. Snake-bites: appraisal of the global situation. Bull World Health Organ. 1998 ; 76: 515-524.
2. Swaroop S, Grab B. Snakebite mortality in the world. Bull World Health Organ. 1954 ; 10: 35-76.
3. Warrell DA, Arnett C. The importance of bites by the sawscaled or carpet viper (Echis carinatus): epidemiological studies in Nigeria and a review of the world literature. Acta Tropica. 1976 ; 33: 307-341.
4. Lalloo DG, Trevett AJ, Saweri A, Naraqi S, Theakston RDG, Warrell DA. The epidemiology of snakebite in Central Province and National Capital District, Papua New Guinea. Trans R Soc Trop Med Hyg. 1995 ; 89: 178-182.
5. Minton SA. Bites by non-native venomous snakes in the United States. Wilderness Environ Med. 1996 ; 7: 297-303.
6. Currie B. Snakebite in tropical Australia, Papua New Guinea and Irian Jaya. Emerg Med. 2000 ; 12: 285-294.
7. Su MJ, Coulter AR, Sutherland SK, Chang CC. The presynaptic neuromuscular blocking agent and phospholipase A2 activity of textilotoxin, a potent toxin isolated from the venom of the Australian brown snake Pseudonaja textilis. Toxicon. 1983 ; 21: 143-151.
8. Jelinek GA, Hamilton T, Hirsch RL. Admissions for suspected snake bite to the Perth adult teaching hospitals, 1979 to 1988. Med J Aust. 1991 ; 155: 761-764.
9. Mead HJ, Jelinek GA. Suspected snakebite in children: a study of 156 patients over 10 years. Med J Aust. 1996 ; 164: 467-470.
10. Currie B. A prospective study of snakebite in tropical Australia [abstract]. Aust N Z J Med. 1999 ; 29: 602-602.
11. Fohlman J, Eaker D, Karlsson E, Thesleff S. Taipoxin, an extremely potent presynaptic neurotoxin from the venom of the Australian snake taipan (Oxyuranus scutellatus scutellatus). Eur J Biochem. 1976 ; 68: 457-469.
12. Hudson BJ. Positive response to edrophonium in death adder (Acanthophis antarcticus) envenomation. Aust N Z J Med. 1988 ; 18: 792-794.
13. Flaschenberger W, Mirtschin PJ. Anticholinesterases as antidotes to envenomation of rats by the death adder (Acanthophis antarcticus). Toxicon. 1994 ; 32 (1). 35-39.
14. Watt G, Theakston RDG, Hayes CG, et al. Positive response to edrophonium in patients with neurotoxic envenoming by cobras (Naja naja philippinensis). N Engl J Med. 1986 ; 315: 1444-1448.
15. Currie B, Fitzmaurice M, Oakley J. Resolution of neurotoxicity with anticholinesterase therapy in death-adder envenomation. Med J Aust. 1988 ; 148: 522-525.
16. Trevett AJ, Lalloo DG, Nwokolo NC, et al. The efficacy of antivenom in the treatment of bites by the Papuan taipan (Oxyuranus scutellatus canni). Trans R Soc Trop Med Hyg. 1995 ; 89: 322-325.
17. Hutton RA, Warrell DA. Action of snake venom components on the haemostatic system. Blood Rev. 1993 ; 7: 176-189.
18. Sano-Martins IS, Fan HW, Castro SC, et al. Reliability of the simple 20 minute whole blood clotting test (WBCT20) as an indicator of low plasma fibrinogen concentration in patients envenomed by Bothrops snakes. Toxicon. 1994 ; 32: 1045-1050.
19. Yip L. Rational use of crotalidae polyvalent immune Fab (ovine) in the management of crotaline bite. Ann Emerg Med. 2002 ; 39: 648-650.
20. Harris JB, Maltin CA. Myotoxic activity of the crude venom and the principal neurotoxin, taipoxin, of the Australian taipan, Oxyuranus scutellatus. Br J Pharmacol. 1982 ; 76: 61-75.
21. Tibballs J, Sutherland S, Kerr S. Studies on Australian snake venom, part 1: the haemodynamic effects of brown snake (Pseudonaja) species in the dog. Anaesth Intensive Care. 1989 ; 17: 466-469.
22. Warrell DA. 'To search and studdy out the secrett of tropical diseases by way of experiment.' Clin Med. 2001 ; 1: 485-494.
23. Blackman JR, Dillon S. Venomous snakebite: past, present, and future treatment options. J Am Board Fam Pract. 1992 ; 5: 399-405.
24. Sutherland SK, Coulter AR, Harris RD. Rationalisation of first aid measures for elapid snakebite. Lancet. 1979 ; 1: 183-186.
25. Howarth DM, Southee AE, Whyte IM. Lymphatic flow rates and first-aid in simulated peripheral snake or spider envenomation. Med J Aust. 1994 ; 161: 695-700.
26. Jamieson R, Pearn J. An epidemiological and clinical study of snake-bites in childhood. Med J Aust. 1989 ; 150: 698-702.
27. Pearn J, Morrison J, Charles N, Muir V. First-aid for snakebite: efficacy of a constrictive bandage with limb immobilization in the management of human envenomation. Med J Aust. 1981 ; 2: 293-295.
28. Murrell GM. The effectiveness of the pressure/ immobilization first aid technique in the case of a tiger snake bite. Med J Aust. 1981 ; 2: 295-295.
29. Sutherland SK, Coulte AR. Early management of bites by the eastern diamondback rattlesnake (Crotalus adamanteus): studies in monkeys (Macaca fascicularis). Am J Trop Med Hyg. 1981 ; 30: 497-500.
30. Tun-Pe, Aye-Aye-Myint, Khin-Ei-Han, Thi-Ha, Tin-Nu-Swe. Local compression pads as a first-aid measure for victims of bites by Russell's viper (Daboia russelii siamensis) in Myanmar. Trans R Soc Trop Med Hyg. 1995 ; 89: 293-295.
31. Pe T, Mya S, Myint AA, Aung NN, Kyu KA, Oo T. Field trial of efficacy of local compression immobilization first-aid technique in Russell's viper (Daboia russelii siamensis) bite patients. Southeast Asian J Trop Med Public Health. 2000 ; 31: 346-348.
32. Tibballs J, Sutherland SK, Kerr S. Studies on Australian snake venoms, part II: the haematological effects of brown snake (Pseudonaja) species in the dog. Anaesth Intensive Care. 1991 ; 19: 338-342.
33. Barnes JM, Trueta J. Absorption of bacteria, toxins and snake venoms from the tissues. Lancet. 1941 ; 1: 623-626.
34. Currie B. Snakebite in Australia: moving from anecdotes to prospective studies. Emerg Med (Fremantle). 2003 ; 15: 406-408.
35. WHO/SEARO guidelines for the clinical management of snake bites in the Southeast Asian region. Southeast Asian J Trop Med Public Health. 1999 ; 30: 1-85.
36. Morrison JJ, Pearn JH, Covacevich J, Nixon J. Can Australians identify snakes? Med J Aust. 1983 ; 2: 66-70.
37. Sprivulis P, Jelinek G. Fatal intracranial haematomas in two patients with Brown snake envenomation. Med J Aust. 1995 ; 162: 215-216.
38. Lalloo DG, Theakston RD. Snake antivenoms. J Toxicol Clin Toxicol. 2003 ; 41: 277-290, 317-327.
39. Meyer WP, Habib AG, Onayade AA, et al. First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom. Am J Trop Med Hyg. 1997 ; 56: 291-300.
40. Ariaratnam CA, Sjostrom L, Raziek Z, et al. An open, randomized comparative trial of two antivenoms for the treatment of envenoming by Sri Lankan Russell's viper (Daboia russelii russelii). Trans R Soc Trop Med Hyg. 2001 ; 95: 74-80.
41. Dart RC, Seifert SA, Boyer LV, et al. A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med. 2001 ; 161: 2030-2036.
42. Sutherland SK. Antivenom use in Australia: premedication, adverse reactions and the use of venom detection kits. Med J Aust. 1992 ; 157: 734-739.
43. Chippaux JP, Lang J, Eddine SA, et al. Clinical safety of a polyvalent F(ab')2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. VAO (Venin Afrique de l'Ouest) Investigators. Trans R Soc Trop Med Hyg. 1998 ; 92: 657-662.
44. Laing GD, Theakston RD, Leite RP, da Silva WD, Warrell DA. Comparison of the potency of three Brazilian Bothrops antivenoms using in vivo rodent and in vitro assays. BIASG (Butantan Institute Antivenom Study Group). Toxicon. 1992 ; 30: 1219-1225.
45. Malasit P, Warrell DA, Chanthavanich P, et al. Prediction, prevention, and mechanisms of early (anaphylactic) antivenom reactions in victims of snake bites. BMJ. 1986 ; 292: 17-20.
46. Phillips RE, Theakston RD, Warrell DA, et al. Paralysis, rhabdomyolysis and haemolysis caused by bites of Russell's viper (Vipera russelli pulchella) in Sri Lanka: failure of Indian (Haffkine) antivenom. Q J Med. 1988 ; 68: 691-715.
47. Trinca GF. The treatment of snakebite. Med J Aust. 1963 ; 1: 275-280.
48. Tibballs J, Sutherland S. The efficacy of antivenom in prevention of cardiovascular depression and coagulopathy induced by brown snake (Pseudonaja) species venom. Anaesth Intensive Care. 1991 ; 19: 530-534.
49. Sprivulis P, Jelinek GA, Marshall L. Efficacy and potency of antivenoms in neutralizing the procoagulant effects of Australian snake venoms in dog and human plasma. Anaesth Intensive Care. 1996 ; 24: 379-381.
50. Ho M, Warrell DA, Looareesuwan S, et al. Clinical significance of venom levels in patients envenomed by the Malayan pit viper (Calloselasma rhodostoma). Am J Trop Med Hyg. 1986 ; 35 (3). 579-587.
51. Audebert F, Sorkine M, Bon C. Envenoming by viper bites in France: clinical gradation and biological quantification by ELISA. Toxicon. 1992 ; 30: 599-609.
52. Warrell D. Treatment of snake bite in the Asia Pacific region: a personal view. In: Gopalakrishnakone P, Chao L, eds. Snakes of Medical Importance (Asia Pacific Region). Singapore: National University of Singapore ; 1990.
53. Pepin S, Lutsch C, Grandgeorge M, Scherrmann JM. Snake F(ab')2 antivenom from hyperimmunized horse: pharmacokinetics following intravenous and intramuscular administrations in rabbits. Pharm Res. 1995 ; 12: 1470-1473.
54. Riviere G, Choumet V, Audebert F, et al. Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy. J Pharmacol Exp Ther. 1997 ; 281: 1-8.
55. Theakston RDG. An objective approach to antivenom therapy and assessment of first-aid measures in snake bite. Ann Trop Med Parasitol. 1997 ; 91: 857-865.
56. Premawardhena AP, de Silva CE, Fonseka MM, Gunatilake SB, de Silva HJ. Low dose subcutaneous adrenaline to prevent acute adverse reactions to antivenom serum in people bitten by snakes: randomised, placebo controlled trial. BMJ. 1999 ; 318: 1041-1043.
57. Gawarammana IB, Kularatne SA, Dissanayake WP, Kumarasiri RP, Senanayake N, Ariyasena H. Parallel infusion of hydrocortisone chlorpheniramine bolus injection to prevent acute adverse reactions to antivenom for snakebites. Med J Aust. 2004 ; 180: 20-23.
58. Fan HW, Marcopito LF, Cardoso JL, et al. Sequential randomised and double blind trial of promethazine prophylaxis against early anaphylactic reactions to antivenom for Bothrops snake bites. BMJ. 1999 ; 318: 1451-1452.
59. Gold BS, Dart RC, Barish RA. Bites of venomous snakes. N Engl J Med. 2002 ; 347: 347-356.
60. Christensen PA. The stability of refined antivenin. Toxicon. 1975 ; 13: 75-77.
61. Dart RC, Seifert SA, Carroll L, et al. Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med. 1997 ; 30: 33-39.
62. Boyer LV, Seifert SA, Cain JS. Recurrence phenomena after immunoglobulin therapy for snake envenomations, part 2: guidelines for clinical management with crotaline Fab antivenom. Ann Emerg Med. 2001 ; 37: 196-201.
63. Bogdan GM, Dart RC, Falbo SC, McNally J, Spaite D. Recurrent coagulopathy after antivenom treatment of crotalid snakebite. South Med J. 2000 ; 93: 562-566.
64. LoVecchio F, Klemens J, Welch S, Rodriguez R. Antibiotics are rarely required following rattlesnake envenomation (ACEP research forum). Ann Emerg Med. 1999 ; 34: S28 - S28.
65. Warrell DA. Bites of venomous snakes. N Engl J Med. 2002 ; 347: 1804-1805.
66. Blaylock RS. Normal oral bacterial flora from some southern African snakes. Onderstepoort J Vet Res. 2001 ; 68: 175-182.
67. Theakston RD, Phillips RE, Looareesuwan S, Echeverria P, Makin T, Warrell DA. Bacteriological studies of the venom and mouth cavities of wild Malayan pit vipers (Calloselasma rhodostoma) in southern Thailand. Trans R Soc Trop Med Hyg. 1990 ; 84: 875-879.
68. de Andrade JG, Pinto RN, de Andrade AL, Martelli CM, Zicker F. Bacteriologic study of abscesses caused by bites of snakes of the genus Bothrops [in Portuguese]. Rev Inst Med Trop Sao Paulo. 1989 ; 31: 363-367.
69. Wilson SC, Vrahas MS, Berson L, Paul EM. A simple method to measure compartment pressures using an intravenous catheter. Orthopedics. 1997 ; 20: 403-406.
70. Southern DA, Callanan VI, Gordon GS. Severe envenomation by the taipan (Oxyuranus scutellatus). Med J Aust. 1996 ; 165: 662-664.
71. Tin-Nu-Swe, Myint-Lwin, Khin-Ei-Han, Tun T, Tun-Pe. Heparin therapy in Russell's viper bite victims with disseminated intravascular coagulation: a controlled trial. Southeast Asian J Trop Med Public Health. 1992 ; 23: 282-287.
72. Kelen EM, Rosenfeld G, Vainzof M, Machado ZC. Experimental defibrination and bothropase: a study on the fibrinolytic mechanism in vivo. Haemostasis. 1978 ; 7: 35-45.
73. Lalloo DG, Trevett AJ, Nwokolo N, et al. Electrocardiographic abnormalities in patients bitten by taipans (Oxyuranus scutellatus canni) and other elapid snakes in Papua New Guinea. Trans R Soc Trop Med Hyg. 1997 ; 91: 53-56.
74. Moore RS. Second-degree heart block associated with envenomation by Vipera berus. Arch Emerg Med. 1988 ; 5: 116-118.
75. Warrell DA, Ormerod LD, Davidson NM. Bites by puffadder (Bitis arietans) in Nigeria, and value of antivenom. BMJ. 1975 ; 4: 697-700.
76. Karlson-Stiber C, Persson H, Heath A, Smith D, al-Abdulla IH, Sjostrom L. First clinical experiences with specific sheep Fab fragments in snake bite: report of a multicentre study of Vipera berus envenoming. J Intern Med. 1997 ; 241: 53-58.
77. Smith J, Greaves I. Crush injury and crush syndrome: a review. J Trauma. 2003 ; 54: S226 - S230.
78. Eneas JF, Schoenfeld PY, Humphreys MH. The effect of infusion of mannitol-sodium bicarbonate on the clinical course of myoglobinuria. Arch Intern Med. 1979 ; 139: 801-805.
79. Homsi E, Barreiro MF, Orlando JM, Higa EM. Prophylaxis of acute renal failure in patients with rhabdomyolysis. Ren Fail. 1997 ; 19: 283-288.
80. Better OS, Stein JH. Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Engl J Med. 1990 ; 322: 825-829.
81. Jeyarajah R. Russell's viper bite in Sri Lanka: a study of 22 cases. Am J Trop Med Hyg. 1984 ; 33: 506-510.
82. Chugh KS, Aikat BK, Sharma BK, Dash SC, Mathew MT, Das KC. Acute renal failure following snakebite. Am J Trop Med Hyg. 1975 ; 24: 692-697.
83. Shastry JC, Date A, Carman RH, Johny KV. Renal failure following snake bite: a clinicopathological study of nineteen patients. Am J Trop Med Hyg. 1977 ; 26: 1032-1038.
84. Gundappa RK, Sud K, Kohli HS, et al. Snakebite induced acute interstitial nephritis: report of a rare entity. Ren Fail. 2002 ; 24: 369-372.
85. Trang TT, Phu NH, Vinh H, et al. Acute renal failure in patients with severe falciparum malaria. Clin Infect Dis. 1992 ; 15: 874-880.
86. Laing GD, Lee L, Smith DC, Landon J, Theakston RD. Experimental assessment of a new, low-cost antivenom for treatment of carpet viper (Echis ocellatus) envenoming. Toxicon. 1995 ; 33: 307-313.
87. Theakston RD, Warrell DA. Crisis in snake antivenom supply for Africa. Lancet. 2000 ; 356: 2104-2104.
88. Cheng AC, Winkel KD. Snakebite and antivenoms in the Asia-Pacific: wokabaut wantaim, raka hebou ("walking together"). Med J Aust. 2001 ; 175: 648-651.
89. Laing GD, Renjifo JM, Ruiz F, et al. A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa. Toxicon. 2003 ; 42: 35-41.
90. Phu NH, Hien TT, Mai NT, et al. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med. 2002 ; 347: 895-902.
91. Thalley BS, Carroll SB. Rattlesnake and scorpion antivenoms from the egg yolks of immunized hens. Biotechnology (N Y). 1990 ; 8: 934-938.
92. Carroll SB, Thalley BS, Theakston RD, Laing G. Comparison of the purity and efficacy of affinity purified avian antivenoms with commercial equine crotalid antivenoms. Toxicon. 1992 ; 30: 1017-1025.